TY  - JOUR
AU  - Beaulieu, Serge
AU  - Saury, Sybille
AU  - Goulet, Sonia
AU  - Poirier, Nancy
PY  - 2018
DA  - 2018/11/05
TI  - Impacts of Mindfulness-Based Cognitive Therapy (MBCT) on the Psychological and Functional Wellbeing of Patients with Bipolar Disorders
JO  - OBM Integrative and Complementary Medicine
SP  - 028
VL  - 03
IS  - 04
AB  - Background: This time series analysis investigated variations in psychic and somatic anxiety during and after completion of MBCT compared to baseline in patients diagnosed with BD. Secondary variables considered were sleep quality and quality of life, as well as depressive and manic symptoms.
Methods: HAMD-29, HAMD-7 and YMRS were administered at baseline (n=34), and every two weeks until the end of the eight-week program.  PSQI (n=22) and Q-LES-Q-SF (n=29) were also administered at pre, mid- and post- MBCT assessments. 
Results: Twenty-four (n=24) participants completed at least four out the eight sessions of MBCT. Post-intervention relative to baseline, psychic anxiety dropped largely (Cohen d=0.74), whilst somatic anxiety remained unchanged (Cohen d=-0.01). In subgroups based on pre-MBCT mental status (anxious/non-anxious, depressed/non-depressed), anxious participants sustained a very strong decline in anxiety (Cohen d=1.67), enough so that they no longer differed from non-anxious participants post-MBCT (p=0.261). A similar post-MBCT convergence was observed between depressed vs. non-depressed participants at baseline (Cohen d=1.03). A slight surge of depressive, anxious, and manic symptoms was noted at Week 6. Sleep quality and quality of life improved post-MBCT relative to baseline with a moderate effect size (Cohen d=0.57 and 0.70, respectively).
Conclusions:  BD diagnosed participants with more symptoms of anxiety and depression at baseline appeared to benefit the most from MBCT. A strong effect on psychic anxiety was found, but none on somatic anxiety. Better sleep quality and quality of life were observed. Manic symptoms improved slightly. More research, especially randomized control trials, are warranted.
SN  - 2573-4393
UR  - https://doi.org/10.21926/obm.icm.1804028
DO  - 10.21926/obm.icm.1804028
ID  - Beaulieu2018
ER  -